˅
˄

Analytical & Technical Leadership

From early-phase feasibility to final design requirements, we can meet the needs of challenging drug formulations.

  • Feasibility and early-phase development capabilities
  • Human tolerability and human factors studies
  • Proven ability to develop challenging drug formulations
  • Preclinical and clinical capabilities
  • Regulatory leadership and expert data analysis to support submissions and filings
˅
˄

Innovative Devices

Refined over several device generations, Kindeva’s microstructured systems are designed for consistent intradermal delivery of vaccines and biologics. Our patient-friendly technology is available in two formats, providing an option of delivery routes to enable your commercial success.

  • Solid Microstructures – offers potential for increased immunogenicity, dose sparing, cold chain elimination, and increased patient convenience via self-administration
  • Hollow Microstructures – offers reproducible intradermal delivery of a wide range of viscosities
˅
˄

Operational Excellence

With sophisticated project management, rigorous quality processes, manufacturing excellence, and cGMP facilities, Kindeva supports a reliable supply chain for your program.

  • Automated Array Molding and Packaging
  • Aseptic Array Coating for Solid Microstructures
  • Qualified Equipment for Device Assembly Process
  • Manufacturing capability for Preclinical, Clinical, and Scale-up Activities

A history of launching next-generation drug delivery systems

Learn more